Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments Read more
Soligenix Receives European Patent for Formulation of Synthetic Hypericin to Treat Psoriasis Read more
Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa Read more